Analysis of the expression of cell cycle regulators in Ewing cell lines:: EWS-FLI-1 modulates p57KIP2 and c-Myc expression

被引:137
作者
Dauphinot, L
De Oliveira, C
Melot, T
Sevenet, N
Thomas, V
Weissman, BE
Delattre, O
机构
[1] Inst Curie, Lab Pathol Mol Canc, INSERM U509, F-75248 Paris 05, France
[2] Univ N Carolina, Lineberger Canc Ctr 345, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
Ewing tumour; cell cycle; EWS-FLI-1; c-Myc; p57(KIP2);
D O I
10.1038/sj.onc.1204437
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ewing tumour is characterized by specific chromosome translocations which fuse EU'S to a subset of genes encoding ETS transcription factors, most frequently FLI-1. We report the analysis of the expression of various cell cycle regulators both in Ewing tumour derived cell lines and in different cellular models with either inducible or constitutive EWS-FLI-1 cDNA expression. In Ewing cell lines, cyclin D1, CDK4, Rb, p27(KIP1) and c-Myc were consistently highly expressed whereas p57(KIP2), p15(INK4B) and p14(ARF) demonstrated undetectable or low expression levels. The amount of p16(INK4A), p21(CIP1), p18(INKAC) and CDK6 was variable from one cell line to the other, The inducible expression of EWS-FLI-1 led to a strong upregulation of c-MSc and a considerable downregulation of p57(KIP2). Other proteins did not show evident modification. High c-Myc and very low p57(KIP2) expression levels were also observed in neuroblastoma NGP cells constitutively expressing EWS-FLI-1 as compared to parental cells. Analysis of the p57(KIP2) promoter indicated that EWS-FLI-1 downregulates, possibly through an indirect mechanism, the transcription of this gene, Finally, we show that ectopic expression of p57(KIP2) in Ewing cells blocks proliferation through a complete G1 arrest. These results suggest that the modulation of p57(KIP2) expression by EWS-FLI-1 is a fundamental step in Ewing tumorigenesis.
引用
收藏
页码:3258 / 3265
页数:8
相关论文
共 35 条
[1]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[2]   EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction [J].
Arvand, A ;
Bastians, H ;
Welford, SM ;
Thompson, AD ;
Ruderman, JV ;
Denny, CT .
ONCOGENE, 1998, 17 (16) :2039-2045
[3]   DNA-BINDING AND TRANSCRIPTIONAL ACTIVATION PROPERTIES OF THE EWS-FLI-1 FUSION PROTEIN RESULTING FROM THE T(1122) TRANSLOCATION IN EWING SARCOMA [J].
BAILLY, RA ;
BOSSELUT, R ;
ZUCMAN, J ;
CORMIER, F ;
DELATTRE, O ;
ROUSSEL, M ;
THOMAS, G ;
GHYSDAEL, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3230-3241
[4]   Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer [J].
de Medina, SGD ;
Salomon, L ;
Colombel, M ;
Abbou, CC ;
Bellot, J ;
Thiery, JP ;
Radvanyi, F ;
Van der Kwast, TH ;
Chopin, DK .
HUMAN PATHOLOGY, 1998, 29 (09) :1005-1012
[5]   GENE FUSION WITH AN ETS DNA-BINDING DOMAIN CAUSED BY CHROMOSOME-TRANSLOCATION IN HUMAN TUMORS [J].
DELATTRE, O ;
ZUCMAN, J ;
PLOUGASTEL, B ;
DESMAZE, C ;
MELOT, T ;
PETER, M ;
KOVAR, H ;
JOUBERT, I ;
DEJONG, P ;
ROULEAU, G ;
AURIAS, A ;
THOMAS, G .
NATURE, 1992, 359 (6391) :162-165
[6]  
Feinberg AP, 1999, CANCER RES, V59, p1743S
[7]   Transcriptional regulation of the p21(WAF1/ClP1) gene [J].
Gartel, AL ;
Tyner, AL .
EXPERIMENTAL CELL RESEARCH, 1999, 246 (02) :280-289
[8]   Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein [J].
Hahm, KB ;
Cho, KN ;
Lee, C ;
Im, YH ;
Chang, J ;
Choi, SG ;
Sorensen, PHB ;
Thiele, CJ ;
Kim, SJ .
NATURE GENETICS, 1999, 23 (02) :222-227
[9]   P53 MUTATIONS IN HUMAN TUMORS WITH CHIMERIC EWS/FLI-1 GENES [J].
HAMELIN, R ;
ZUCMAN, J ;
MELOT, T ;
DELATTRE, O ;
THOMAS, G .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :336-340
[10]   Critical role for the 310 helix region of p57Kip2 in cyclin-dependent kinase 2 inhibition and growth suppression [J].
Hashimoto, Y ;
Kohri, K ;
Kaneko, Y ;
Morisaki, H ;
Kato, T ;
Ikeda, K ;
Nakanishi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :16544-16550